HempFusion Launches Sleep and Stress Products With Twice the Amount of CBD
February 11 2021 - 7:05AM
Business Wire
HempFusion Wellness Inc. (TSX:CBD.U) (US:CBDHF) (FWB:8OO)
(“HempFusion” or the “Company”), a leading health and wellness CBD
company utilizing the power of whole-food hemp nutrition, is
pleased to announce it has increased its product offering to 48
SKUs by introducing its new and improved Sleep and Stress products
with twice the amount of CBD per serving.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20210211005284/en/
HempFusion 300 mg Sleep and Stress
Support CBD Capsules (Photo: Business Wire)
“Global consumers are becoming increasingly familiar with CBD
and its potential benefits to their daily routine,” commented Jason
Mitchell, N.D., HempFusion’s co-founder and chief executive
officer. “After conducting months of extensive consumer research,
it was clear that the majority of our customers and consumers in
the market are seeking products with increased CBD percentages. It
has always been HempFusion’s goal to provide new and innovative
products that consumers are looking for. We are proud to launch our
new and improved Sleep and Stress supporting products and are
excited by the potential they bring to the CBD marketplace,”
continued Dr. Mitchell.
The new SKUs are now available for purchase on HempFusion’s
website. Visit HempFusion.com for more information on the Sleep and
Stress products in addition to HempFusion’s complete product
range.
HempFusion’s new and improved Sleep and Stress products aim to
support relaxation for consumers by providing more restful night’s
sleep and easing occasional stress. The products include:
- Twice the amount of CBD (300 mg per bottle)
- GABA, an amino acid that supports mental relaxation
- ASHWAGANDHA that helps you better deal with daily occasional
stress
- CBD and a broad array of other important cannabinoids,
terpenes, and more that supports the endocannabinoid system
- No THC - Tested to contain less than 0.01% ∆9-THC
ABOUT HEMPFUSION
HempFusion is a leading health and wellness CBD company
utilizing the power of whole-food hemp nutrition. HempFusion
distributes its family of brands, including HempFusion, Probulin
Probiotics, Biome Research, and HF Labs, to approximately 4,000
retail locations across all 50 states of the United States and
select international locations. Built on a foundation of regulatory
compliance and human safety, HempFusion’s diverse product portfolio
comprises 48 SKUs including tinctures, proprietary FDA Drug Listed
Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and
more. With a strong focus on research and development, HempFusion
has an additional 30 products under development. HempFusion is a
board member of the US Hemp Roundtable, and HempFusion’s
wholly-owned subsidiary, Probulin Probiotics, is one of the
fastest-growing probiotics companies in the United States,
according to SPINs reported data. HempFusion’s CBD products are
based on a proprietary Whole Food Hemp Complex™ and are available
in-store or by visiting HempFusion online at www.hempfusion.com or
www.probulin.com.
Follow HempFusion on Twitter, Facebook and Instagram and
Probulin on Twitter, Facebook and Instagram.
FORWARD-LOOKING STATEMENTS
This news release contains forward-looking statements and
forward-looking information within the meaning of Canadian
securities legislation (collectively, “forward-looking
statements”) that relate to HempFusion’s current expectations
and views of future events. Any statements that express, or involve
discussions as to, expectations, beliefs, plans, objectives,
assumptions or future events or performance (often, but not always,
through the use of words or phrases such as “will likely result”,
“are expected to”, “expects”, “will continue”, “is anticipated”,
“anticipates”, “believes”, “estimated”, “intends”, “plans”,
“forecast”, “projection”, “strategy”, “objective” and “outlook”)
are not historical facts and may be forward-looking statements and
may involve estimates, assumptions and uncertainties which could
cause actual results or outcomes to differ materially from those
expressed in such forward-looking statements. No assurance can be
given that these expectations will prove to be correct and such
forward-looking statements included in this news release should not
be unduly relied upon. These statements speak only as of the date
of this news release. In particular and without limitation, this
news release contains forward-looking statements relating to the
Company’s goal to provide new and innovative products and the
Company’s other plans, focus and objectives.
Forward-looking statements are based on a number of assumptions
and are subject to a number of risks and uncertainties, many of
which are beyond HempFusion’s control, which could cause actual
results and events to differ materially from those that are
disclosed in or implied by such forward-looking statements. Such
risks and uncertainties include, but are not limited to, the impact
and progression of the COVID-19 pandemic and other factors set
forth under “Forward-Looking Statements” and “Risk Factors” in the
final long form prospectus of the Company dated December 17, 2020
and available under the Company’s profile on SEDAR at
www.sedar.com. HempFusion undertakes no obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be required
by law. New factors emerge from time to time, and it is not
possible for HempFusion to predict all of them or assess the impact
of each such factor or the extent to which any factor, or
combination of factors, may cause results to differ materially from
those contained in any forward-looking statement. Any
forward-looking statements contained in this news release are
expressly qualified in their entirety by this cautionary
statement.
Neither the TSX nor its Regulation Services Provider (as that
term is defined in the policies of the TSX) accepts responsibility
for the adequacy or accuracy of this release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210211005284/en/
Jason Mitchell, N.D. Chief Executive Officer and Director Email:
ir@hempfusion.com Phone: 416-803-5638
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Mar 2024 to Apr 2024
HempFusion Wellness (TSX:CBD.U)
Historical Stock Chart
From Apr 2023 to Apr 2024